The second day of the conference will begin with opening remarks by NYSCF CEO Susan L. Solomon and welcoming remarks by Dr. Melton. Panels will explore disease-specific stem cell research in the areas of diabetes (chaired by Robin Goland, MD, Co-Director, Naomi Berrie Diabetes Center), cancer and blood disease(chaired by Ihor Lemischka, PhD, Director, Black Family Stem Cell Institute), repairing heart and muscles (chaired by John D. Gearhart, PhD, Director, University of Pennsylvania Institute for Regenerative Medicine), and neurodegeneration/spinal cord injury (chaired by Gerald Fischbach, MD, Scientific Director, The Simons Foundation). The final panel will focus on the latest research efforts in the area of derivation and characterization of new pluripotent stem cell lines (chaired by Shahin Rafii, MD, Director, Ansary Center for Stem Cell Therapeutics, Weill Cornell Medical College).
Speakers will include: Harry Heimberg, MD, PhD, Investigator, University of Brussels; Christopher Henderson, PhD, Co-Director, Motor Neuron Center at Columbia University; Michael A. Rudnicki, PhD, FRSC, Director, Sprott Centre for Stem Cell Research, Ottawa Health Research Institute; Tom Okarma, MD, PhD, President and CEO, Geron Corp.; Amy Wagers, PhD, Assistant Professor of Stem Cell and Regenerative Biology, Joslin Diabetes Center, Harvard University and HSCI; and Owen N. Witte, MD, Director, Broad Center of Regenerative Medicine and Stem Cell Research, UCLA.
George Daley, MD, PhD, Associate Professor of Pediatrics in the Division of Hematology/Oncology at Children's Hospital Boston, Associate Professor of B
'/>"/>
| Contact: Adam Pockriss apockriss@rubenstein.com 212-843-8286 New York Stem Cell Foundation Source:Eurekalert |